Related Experiment Video
Updated: Jun 4, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
MicroRNAs as Biomarker in Rheumatoid Arthritis: Pathogenesis to Clinical Relevance
Tooba Qamar1, Md Samsuddin Ansari2,3, Masihuddin4
1Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, Uttar Pradesh, India.
Abstract:
MicroRNAs (miRNAs) have emerged as intricate players in rheumatoid arthritis (RA), holding promise as discerning biomarkers for diagnostic and prognostic purposes. The lack of sensitivity and specificity in current diagnostic techniques, such as rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA), causes diagnosis delays in RA. The miR-146a and miR-155 act in inflammatory cascades and reduce joint deterioration, and miR-223 is paradoxical, acting differently in different illness scenarios. The microenvironment of RA is shaped by the complex modulation of gene expression and cytokine dynamics by miR-126 and miR-24. miRNAs serve as a promising candidate for precision medicine in the management of RA. There are obstacles encountered in validation, delivery optimization, and off-target effect mitigation before miRNA-based biomarkers may be applied in clinical settings. Machine learning (ML) and artificial intelligence (AI) have been used to integrate miRNA expression patterns with clinical data to greatly advance the treatment of RA. Because of the disease's inherent complexity and variability, these state-of-the-art models provide accurate predictions regarding the onset, development, and response to treatment of RA. By using clinical information and miRNA expression data, ML algorithms are revolutionizing the treatment of RA by predicting the onset and course of the disease with remarkably high accuracy. The development of therapeutic modalities and miRNA profiling has great potential to transform the diagnosis, prognosis, and treatment of RA, providing fresh hope for better patient outcomes.
Insights
MicroRNAs (miRNAs) show potential as rheumatoid arthritis (RA) biomarkers, improving diagnosis and treatment. Machine learning integrates miRNA data for precise RA prediction and management, offering new hope for patients.
Area of Science:
- Biochemistry and Molecular Biology
- Immunology
- Computational Biology
Background:
- Rheumatoid arthritis (RA) diagnosis faces challenges due to low sensitivity and specificity of current biomarkers like rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA).
- MicroRNAs (miRNAs) play crucial roles in RA pathogenesis, influencing inflammatory pathways and gene expression.
- Specific miRNAs, including miR-146a, miR-155, miR-223, miR-126, and miR-24, are implicated in RA's inflammatory cascades and disease progression.
Purpose of the Study:
- To explore the potential of miRNAs as diagnostic and prognostic biomarkers for rheumatoid arthritis (RA).
- To investigate the role of specific miRNAs in RA pathogenesis and their modulation of the disease microenvironment.
- To highlight the application of machine learning (ML) and artificial intelligence (AI) in integrating miRNA expression with clinical data for improved RA management.
Main Methods:
- Analysis of miRNA expression patterns in the context of rheumatoid arthritis (RA).
- Review of existing literature on the role of specific miRNAs (e.g., miR-146a, miR-155, miR-223, miR-126, miR-24) in RA.
- Integration of miRNA expression data with clinical information using machine learning (ML) and artificial intelligence (AI) algorithms.
Main Results:
- Certain miRNAs demonstrate potential as sensitive and specific biomarkers for RA diagnosis and prognosis.
- miRNAs like miR-146a and miR-155 are involved in regulating inflammatory responses and joint damage in RA.
- ML and AI models effectively integrate miRNA expression profiles with clinical data, enabling accurate predictions of RA onset, progression, and treatment response.
Conclusions:
- miRNAs represent a promising avenue for precision medicine in rheumatoid arthritis (RA) management.
- Overcoming challenges in miRNA validation, delivery, and off-target effects is crucial for clinical application.
- The synergy of miRNA profiling and advanced computational approaches like ML/AI holds significant potential to revolutionize RA diagnosis, prognosis, and treatment.
More Related Videos
13:36Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
11:03A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model
Published on: October 30, 2019
Related Concept Videos
MicroRNAs
The JAK-STAT Signaling Pathway
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...